 BrainStorm Cell Therapeutics Inc. NASDAQ: BCLI, a leading developer of adult stem cell therapies for neurodegenerative diseases, announced today the publication of a manuscript titled, Effects of MSC-NTF cells on T and B regulatory cell function in ALS in the journal Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 